Skip to main content
SpringerLink
Log in
Book cover

Pediatric and Adolescent Osteosarcoma pp 289–308Cite as

Osteosarcoma: The COSS Experience

  • Chapter
  • First Online:

Part of the book series: Cancer Treatment and Research ((CTAR,volume 152))

Abstract

COSS, the interdisciplinary Cooperative German–Austrian–Swiss Osteosarcoma Study Group, was founded in 1977 and has since registered some 3,500 bone sarcoma patients from over 200 institutions. For the purpose of the Pediatric and Adolescent Osteosarcoma Conference in Houston, March 2008, the outcomes of 2,464 consecutive patients with high-grade central osteosarcoma, who had been diagnosed between 1980 and 2005 and had been treated on neoadjuvant COSS protocols, were reviewed. Intended treatment had included surgery and multidrug chemotherapy, with high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide being used in most protocols. After a median follow-up of 7.31 years for 1,654 survivors, 5- and 10-year survival estimates were 0.748/0.695 for 2,017 patients with localized extremity tumors and 0.369/0.317 for 444 patients with axial tumors or/and primary metastases, respectively. Tumor response to preoperative chemotherapy was of independent prognostic significance. Over the years, there was a major shift from amputation towards limb-salvage. This development was least evident for patients below the age of 10. While survival expectancies improved from the first to the second half of the recruitment period, no further improvement was evident within the latter period. In the manuscript, the results described above are discussed based on the findings of the previous analyses of our group.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Winkler K, Beron G, Schellong G, et al. Kooperative Osteosarkomstudie COSS-77: Ergebnisse nach über 4 Jahren. Klin Pädiatr. 1982;194:251-256.

    Article  CAS  PubMed  Google Scholar 

  2. Winkler K, Beron G, Kotz R, et al. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a cooperative German/Austrian study. J Clin Oncol. 1984;2:617-623.

    CAS  PubMed  Google Scholar 

  3. Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol. 1988;6:329-337.

    CAS  PubMed  Google Scholar 

  4. Bielack S, Beck J, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma. Results of the cooperative studies COSS-80 and COSS-82 after 7 and 5 years. Klin Padiatr. 1989;201:275-284.

    Article  CAS  PubMed  Google Scholar 

  5. Winkler K, Bielack S, Delling G, et al. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer. 1990;66:1703-1710.

    Article  CAS  PubMed  Google Scholar 

  6. Bielack S, Wulff B, Delling G, et al. Osteosarcoma of the trunk treated by multimodal therapy: experience of the cooperative osteosarcoma study group COSS. Med Pediatr Oncol. 1995;24:6-12.

    Article  CAS  PubMed  Google Scholar 

  7. Fuchs N, Bielack S, Epler D, et al. Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998;9:893-899.

    Article  CAS  PubMed  Google Scholar 

  8. Bielack S, Kempf-Bielack B, Schwenzer D, et al. Neoadjuvante Therapie des lokalisierten Osteosarkoms der Extremitäten. Erfahrungen der Cooperativen Osteosarkomstudiengruppe COSS an 925 Patienten. Klin Padiatr. 1999a;211:260-270.

    CAS  PubMed  Google Scholar 

  9. Bielack SS, Kempf-Bielack B, Heise U, Schwenzer D, Winkler K. Combined modality treatment for osteosarcoma occurring as a second malignant disease. J Clin Oncol. 1999;17:1164-1174.

    CAS  PubMed  Google Scholar 

  10. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2002;20:776-790.

    Article  PubMed  Google Scholar 

  11. Ozaki T, Flege S, Liljenqvist U, et al. Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group (COSS). Cancer. 2002;94:1069-1077.

    Article  PubMed  Google Scholar 

  12. Ozaki T, Flege S, Kevric M, et al. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. 2003;21:334-341.

    Article  PubMed  Google Scholar 

  13. Kager L, Zoubek A, Pötschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of 202 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group (COSS) protocols. J Clin Oncol. 2003;21:2011-2018.

    Article  PubMed  Google Scholar 

  14. Kaatsch P, Spix C, et al.: Jahresbericht 2005: Deutsches Kinderkrebsregister. Mainz, Germany, Johannes-Gutenberg-Universität, Institut für Medizinische Statistik und Information; 2006

    Google Scholar 

  15. Jaffe N, Paed D, Farber S, et al. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy. Cancer. 1973;31:1367-1373.

    Article  CAS  PubMed  Google Scholar 

  16. Jaffe N, Frei E 3rd, Traggis D, Bishop Y. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med. 1974;291:994-997.

    Article  CAS  PubMed  Google Scholar 

  17. Salzer-Kuntschik M, Brand G, Delling G. Bestimmung des morphologischen Regressionsgrades nach Chemotherapie bei malignen Knochentumoren. Pathologie. 1983;4:135-141.

    CAS  Google Scholar 

  18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.

    Article  Google Scholar 

  19. Mantel M. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.

    CAS  PubMed  Google Scholar 

  20. Cox DR. Regression models and life-tables [with discussion]. J R Stat Soc [B]. 1972;34:187-220.

    Google Scholar 

  21. Jasnau S, Meyer U, Potratz J, et al. Craniofacial osteosarcoma Experience of the cooperative German–Austrian–Swiss osteosarcoma study group. Oral Oncol. 2008;44:286-294.

    Article  PubMed  Google Scholar 

  22. Kager L, Zoubek A, Kastner U, et al. Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol. 2006;24:1535-1541.

    Article  PubMed  Google Scholar 

  23. Kempf-Bielack B, Bielack SS, Jürgens H, et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. 2005;23:559-568.

    Article  PubMed  Google Scholar 

  24. Picci P, Sangiorgi L, Rougraff BT, et al. The relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol. 1994;12:2699-2705.

    CAS  PubMed  Google Scholar 

  25. Bielack S, Kempf-Bielack B, Winkler K. Osteosarcoma: relationship of response to preoperative chemotherapy and type of surgery to local recurrence. J Clin Oncol. 1996;15:683-684.

    Google Scholar 

  26. Hillmann A, Hoffmann C, Gosheger G, Krakau H, Winkelmann W. Malignant tumor of the distal part of the femur or the proximal part of the tibia: endoprosthetic replacement or rotationplasty. Functional outcome and quality-of-life measurements. J Bone Joint Surg Am. 1999;81:462-468.

    Article  CAS  PubMed  Google Scholar 

  27. Abudu A, Grimer RJ, Tillman R, et al. The use of prostheses in skeletally immature patients. Orthop Clin North Am. 2006;37:75-84.

    Article  PubMed  Google Scholar 

  28. Hardes J, Gebert C, Hillmann A, et al. Die Möglichkeiten und Grenzen der Umkehrplastik im operativen Behandlungsplan der primär malignen Knochentumoren. Orthopäde. 2003;32:965-970.

    Article  CAS  PubMed  Google Scholar 

  29. Kotz RI, Windhager R, Dominkus M, Robioneck B, Müller-Daniels H. A self-extending paediatric leg implant. Nature. 2000;406:143-144.

    Article  CAS  PubMed  Google Scholar 

  30. Krepler P, Dominkus M, Toma CD, Kotz R. Endoprosthesis management of the extremities of children after resection of primary malignant bone tumors. Orthopade. 2003;32:1013-1019.

    Article  CAS  PubMed  Google Scholar 

  31. Bielack S, Erttmann R, Winkler K, Landbeck G. Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy. Eur J Cancer Clin Oncol. 1989;25:873-882.

    Article  CAS  PubMed  Google Scholar 

  32. Friedman MA, Carter SK. The therapy of osteogenic sarcoma: current status and thoughts for the future. J Surg Oncol. 1972;4:482-510.

    Article  CAS  PubMed  Google Scholar 

  33. Jaffe N, Frei E. Osteogenic sarcoma: advances in treatment. CA Cancer J Clin. 1976;26:351-359.

    Article  CAS  PubMed  Google Scholar 

  34. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremities. N Engl J Med. 1986;314:1600-1606.

    Article  CAS  PubMed  Google Scholar 

  35. Bielack SS, Machatschek JN, Flege S, Jürgens H. Delaying surgery with chemotherapy for osteosarcoma of the extremities. Expert Opin Pharmacother. 2004;5:1243-1256.

    Article  PubMed  Google Scholar 

  36. Stiller CA, Bielack SS, Jundt G, Steliarova-Foucher E. Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2124-2135.

    Article  CAS  PubMed  Google Scholar 

  37. Bielack S, Kempf-Bielack B, Branscheid D, et al. Second and subsequent recurrences of osteosarcoma: Presentation, treatment, and outcomes of 249 consecutive Cooperative Osteosarcoma Study Group patients. J Clin Oncol. 2009;27:557–65.

    Google Scholar 

Download references

Acknowledgements

We thank all the patients who contributed to the COSS studies, and acknowledge the physicians, nurses, data managers, and support staff of the collaborating centers for their active participation, and the Deutsches Kinderkrebsregister for the exchange of follow-up information and data on secondary malignancies. We particularly appreciate the dedicated work of the staff of the COSS study center and of the members of the COSS reference panels. The COSS studies on which these analyses are based received support from Deutsche Krebshilfe, Bundesministerium für Forschung und Technologie, and Fördergemeinschaft Kinderkrebszentrum Hamburg.

Author information

Authors and Affiliations

  1. Pädiatrie 5 (Onkologie, Hämatologie,Immunologie), Klinikum Stuttgart, Zentrum für Kinder- und Jugendmedizin - Olgahospital, Bismarckstr. 8, D-70176, Stuttgart, Germany

    Stefan Bielack

Authors
  1. Stefan Bielack
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Herbert Jürgens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gernot Jundt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matthias Kevric
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas Kühne
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter Reichardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andreas Zoubek
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mathias Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Winfried Winkelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Rainer Kotz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Bielack .

Editor information

Editors and Affiliations

  1. MD Anderson Cancer Center, University of Texas, Holcombe Blvd. 1515, Houston, 77030-4095, U.S.A.

    Norman Jaffe

  2. Dept. Medical Oncology, Norwegian Radium Hospital, Ullernschaussee 70, Oslo, 0310, Norway

    Oyvind S. Bruland

  3. Orthopädische Klinik, Olgahospital, Bismarckstraße 8, Stuttgart, 70176, Germany

    Stefan Bielack

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bielack, S. et al. (2009). Osteosarcoma: The COSS Experience. In: Jaffe, N., Bruland, O., Bielack, S. (eds) Pediatric and Adolescent Osteosarcoma. Cancer Treatment and Research, vol 152. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-0284-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-0284-9_15

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-0283-2

  • Online ISBN: 978-1-4419-0284-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation